HighVista Strategies »

Adma Biologics shares owned by HighVista Strategies

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 95k 14.66

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Geode Capital Management
Nuveen
Westfield Capital Management Company
Dimensional Fund Advisors
American Century Companies
UBS Group
Thrivent Financial for Lutherans
Citadel Advisors
Capital Research Global Investors
Goldman Sachs Group

View all funds holding Adma Biologics